Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-20

Clinical Trial Update: A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the combination of tamsulosin hydrochloride and solifenacin succinate in men with lower urinary tract symptoms due to benign pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (solifenacin)
  • Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Lower Urinary Tract Symptoms, Prostatic Hyperplasia | Phase 2 | Status: COMPLETED